Incretin-based Drugs Market Size, Trends, Share, Growth, and Opportunity Forecast, 2023 - 2030 Global Industry Analysis by Drug Type (Glucagon-like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors), By Route of Administration (Oral, and Parenteral), By Indication (Type-2 Diabetes, and Chronic Overweight Management), by Distribution Channel (Hospital Pharmacy, Offline Retail Stores, and Online Retail Stores), and by Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)